CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. - Wikidata - wikimedia - TriplyDB

CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility.

CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility.

http://www.wikidata.org/entity/Q44354886

about

Medical physics practice in the next decade Current role of image-guided robotic radiosurgery (Cyberknife(®) ) for prostate cancer treatment New frontiers in radiosurgery for the brain and body.A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.Treatment planning for stereotactic radiosurgery with photon beams.Image-guided focal therapy for prostate cancer.IMRT: delivery techniques and quality assurance.Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma.Is tomotherapy the future of IMRT?Innovative image-guided CyberKnife stereotactic radiotherapy for bladder cancer.Innovative strategies for image-guided proton treatment of prostate cancer.Image-guided radiosurgical ablation of intra- and extra-cranial lesions.Robotic whole body stereotactic radiosurgery: clinical advantages of the Cyberknife integrated system.Intrafractional motion of the prostate during hypofractionated radiotherapy CT-guided fiducial placement for cyberknife stereotactic radiosurgery: an initial experience.Optimal planning strategy among various arc arrangements for prostate stereotactic body radiotherapy with volumetric modulated arc therapy technique.The CyberKnife Robotic Radiosurgery System in 2010.Clinical Outcomes of CyberKnife Radiotherapy in Prostate Cancer Patients: Short-term, Single-Center Experience Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer.A pencil beam dose calculation model for CyberKnife system.CyberKnife radiosurgery for prostate cancer.The tissue plasminogen activator gene promoter: a novel tool for radiogenic gene therapy of the prostate?Multisession Radiosurgery for Sellar and Parasellar Benign Meningiomas: Long-term Tumor Growth Control and Visual Outcome.Will intrafraction repair have negative consequences on extreme hypofractionation in prostate radiation therapy?Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost and whole pelvic radiotherapy for intermediate- and high-risk prostate cancer.Technical note: Image guided internal fiducial placement for stereotactic radiosurgery (CyberKnife).Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer Virtual HDR CyberKnife SBRT for Localized Prostatic Carcinoma: 5-Year Disease-Free Survival and Toxicity Observations.Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer Dosimetric and radiobiological comparison of CyberKnife M6™ InCise multileaf collimator over IRIS™ variable collimator in prostate stereotactic body radiation therapy.Direct tumor in vivo dosimetry in highly-conformal radiotherapy: a feasibility study of implantable MOSFETs for hypofractionated extracranial treatments using the Cyberknife system.A gradient feature weighted Minimax algorithm for registration of multiple portal images to 3DCT volumes in prostate radiotherapy.A strategy to correct for intrafraction target translation in conformal prostate radiotherapy: simulation results.Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT.Radiosurgery of liver tumors: value of robotic radiosurgical device to treat liver tumors.Clinical implementation of target tracking by breathing synchronized delivery.Patient-reported quality of life progression in men with prostate cancer following primary cryotherapy, cyberknife, or active holistic surveillance.Feasibility of four-dimensional conformal planning for robotic radiosurgery.Image-guided stereotactic body radiation therapy for clinically localized prostate cancer: preliminary clinical results.

P2860

Q24606759-BE40DF99-5829-4D56-8DEF-F7DF6E5655FE Q27009327-9C60297A-DCF4-44C7-9906-1E69033AB194 Q30499008-0F9DA853-2662-4FBD-8FDA-34552DB0A1B7 Q35019637-378B6078-918C-4613-B341-54D00C90EA41 Q35101583-04103888-383C-4A3C-958A-5B9ACF56C1B1 Q35245037-4DE2089D-6931-42E8-A897-D3885D2782FE Q35586943-F6FEA583-491F-42D8-9C28-34FD2121D4EE Q35649108-41BA5544-BB99-4889-BD12-30AF855FCB1C Q35755399-00431EAD-F032-4CF3-90DA-5A02056BB836 Q36324461-DF4D456B-7FD1-4F2E-81BD-EEBF300AB107 Q36427226-8E1FC558-112F-40CE-B772-A68F2D33FDED Q36546235-757ACD84-03B2-4ED7-B969-6DDAC6F5EE97 Q36828679-3A9AA515-731C-43B8-886D-4BE32E2E3802 Q37301004-7A7BD344-16E5-426F-9129-656C19379030 Q37631506-FB352260-4FC5-4469-9ABD-22F89F868C47 Q37671472-6365D545-0155-4D1A-9665-E98EEAE2D50F Q37785075-0A5ED9E0-CF2A-4B22-B176-3018CE215079 Q38306112-05BE410C-6F2E-4126-BB59-D0E7B5CE839A Q38437266-CBE6F9D9-3159-44FC-B2C3-3B52C049D6EC Q39248682-25EE7CFD-CA64-40A1-8401-2CEAD7A98EBA Q39841215-F60234FC-EE89-4433-BC79-03F82288AC2A Q39963103-DA83A36C-AF48-4CA8-8890-EC5D03370868 Q40402815-B30CD394-DE42-4A12-B20E-E1FCBF1CC8CA Q40452434-965D60B2-873D-4806-BBFC-3AFC00B19034 Q40858279-67B9EB88-C5C5-4D35-A428-13B9649611B0 Q41767526-A3803B85-2120-4443-B4E8-E51F29B3BFE2 Q41895037-1BE18CB4-0D47-4868-88A4-C456101BA5EE Q41925779-5ED17C31-2B36-447F-99AD-72946F16148B Q42139601-51E5F68E-58F9-4616-80E6-E1D16948F6D2 Q42421068-95CCC95B-CAB3-4628-9FDA-29BAC0D46363 Q42780116-A1F9896A-AEB8-4907-B86A-CF249E076ECA Q42909549-07ED8357-B678-4E4D-9CF8-1BA8C2ABE4BF Q42957579-FFDBC5A9-4D2F-4686-BC00-DFCACE8601B7 Q44931126-2E125C01-B8B0-49B4-8122-EA358A72B14D Q46807769-282E81EC-C3DA-4EB4-88AB-9B7F36B5C839 Q48809198-718C99F6-202C-4538-B298-A76AAFE1A0C2 Q48922655-2145DCAB-BCA6-48A5-8F27-FF273A13C2A1 Q50020871-5C38C86A-E714-4C70-8A5E-57646E726CC5 Q51951010-90C87ABB-E379-4229-83F1-6D93F157D59A Q53274295-6732214F-EABD-4399-816A-8C93330ACB8A

P2860

CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility.

http://www.wikidata.org/entity/Q44354886

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

CyberKnife radiotherapy for lo ...... ale and technical feasibility.

@en

CyberKnife radiotherapy for lo ...... ale and technical feasibility.

@nl

type

label

CyberKnife radiotherapy for lo ...... ale and technical feasibility.

@en

CyberKnife radiotherapy for lo ...... ale and technical feasibility.

@nl

prefLabel

CyberKnife radiotherapy for lo ...... ale and technical feasibility.

@en

CyberKnife radiotherapy for lo ...... ale and technical feasibility.

@nl

P1433

Q44354886-F96126A7-88AF-4398-BACE-A40A6C185C17

P1476

Q44354886-89448A03-22FB-45A9-AB87-1A74F7E8E674

P2093

Q44354886-0BAD3283-1EF5-4106-9BDB-85FAA8465EEC

Q44354886-29E5D34B-6016-42C3-B79B-FFCE6509AB54

Q44354886-A363F0E8-FDB0-4F37-9316-803535AFA696

Q44354886-AEA9E75A-2C3F-4869-B547-E1B346E55F28

P2860

Q44354886-37C92852-4667-47F5-96D1-31C435E9BB75

Q44354886-4A84B7F7-2F68-4F40-A88A-2B4A7487D2E9

Q44354886-A6206D7E-58BB-4240-8A37-D6301353E104

Q44354886-D72A0B5C-48E9-4273-8BB5-1BFDAB681B20

Q44354886-DBCF9CB1-A489-4B84-B8A4-F5B0FD282DD6

Q44354886-E08591E2-B2E0-4759-9D2F-23508D317CEA

Q44354886-F3D75153-E15C-453A-885E-48AEBA6522CC

P304

Q44354886-2CB02C8F-0406-49CD-A952-3CA86C43EC5B

P31

Q44354886-3F8E7EF4-0039-4953-B769-2FF9E108E7B7

P356

Q44354886-8C792AAC-C087-45DD-96B2-A78C0BD1252B

P433

Q44354886-B7443815-BD63-43AD-B71E-25BBDE043DC7

P478

Q44354886-39871797-3DBE-44CB-9554-50CB7E4B310D

P577

Q44354886-A61AF93C-4412-45BE-8E91-8CD8A2FA23F9

P5875

Q44354886-513B8C94-1DF6-4398-8CA7-B63339F4303C

P698

Q44354886-FBD0B94C-34DB-4A4E-9F58-518644444A47

P921

Q44354886-FFF81D41-F266-4A29-8C05-0E89DB16FE28

P356

153303460300200104

P1433

Technology in Cancer Research and Treatment

P1476

CyberKnife radiotherapy for lo ...... ale and technical feasibility.

@en

P2093

Christopher R King

http://www.w3.org/2001/XMLSchema#string

Jenny Hai

http://www.w3.org/2001/XMLSchema#string

Joerg Lehmann

http://www.w3.org/2001/XMLSchema#string

John R Adler

http://www.w3.org/2001/XMLSchema#string

P2860

Is alpha/beta for prostate tumors really low?

Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984).

Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate.

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate.

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.

P304

25-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/153303460300200104

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10865712

http://www.w3.org/2001/XMLSchema#string

P698

12625751

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy